胃内毒神经毒素注射后的阳性肉毒症 - 一个主要的爆发
Tsepo Goerttler1, Martin B Dorner2, Christina van der Linden3
1Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Hospital Essen, University of Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany. lt.goerttler@gmail.com.
Neurological research and practice
|October 30, 2024
概括
在2023年,在欧洲发生了因胃内毒神经毒素 (IBNI) 注射以减肥而导致的阳性虫病爆发. 本病例系列详细介绍了十起严重病例,强调了临床医生意识到肉毒神经毒素风险的必要性.
科学领域:
- 神经学 神经学
- 毒理学 毒理学 毒理学
- 胃肠病学 胃肠病学
背景情况:
- 胃内肉毒神经毒素注射 (IBNI) 是欧洲私立诊所的非标签减肥治疗方法.
- 在土耳其的IBNI程序之后,在2023年2月至3月期间,在欧洲发生了一场阳性肉毒症的爆发.
- 这一案例系列调查了IBNI后严重的阳性肉毒症的临床表现.
研究的目的:
- 描述严重阳性肉毒的临床特征和治疗方法.
- 报告 IBNI.之后记录的最大的阳性肉毒症爆发.
- 提高临床医生对肉毒神经毒素手术风险的认识.
主要方法:
- 追溯分析了十个严重的阳性肉毒的病例.
- 总结了临床过程,急诊室和重症监护室的干预.
- 在奥地利和德国在2023年爆发期间,在IBNI治疗后发生了病例.
主要成果:
- 七名患者呈现出经典的肉毒主义症状,包括双眼视,消化不良,脱节症和下降性.
- 所有十名患者都需要住院治疗,其中六人被送往重症监护室.
- 一些患者需要机械通风;所有患者都恢复了,没有显著的长期缺陷.
结论:
- 这项研究详细介绍了与IBNI相关的最大报告的阳性肉毒症爆发的十起病例.
- 临床医生必须认识到肉毒神经毒素治疗的潜在危险.
- 在涉及肉毒神经毒素的程序中实施降低风险的策略至关重要.
更多相关视频
相关概念视频
Local Anesthetics: Adverse Effects
392
While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
392
Skeletal Muscle Relaxants: Therapeutic Uses
468
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
468
Depolarizing Blockers: Pharmocokinetics
311
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
311
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
656
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
656
Myasthenia Gravis: Overview and Treatment
1.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.2K
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
83
Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
83


